Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Efficacy of Treatment of Non-hereditary Angioedema.

van den Elzen M, Go MFCL, Knulst AC, Blankestijn MA, van Os-Medendorp H, Otten HG.

Clin Rev Allergy Immunol. 2018 Jun;54(3):412-431. doi: 10.1007/s12016-016-8585-0. Review.

2.

NSAIDs and Colorectal Cancer Control: Promise and Challenges.

Tsioulias GJ, Go MF, Rigas B.

Curr Pharmacol Rep. 2015 Oct 1;1(5):295-301. Epub 2015 May 14.

3.

MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis.

Ouyang N, Zhu C, Zhou D, Nie T, Go MF, Richards RJ, Rigas B.

PLoS One. 2012;7(7):e41585. doi: 10.1371/journal.pone.0041585. Epub 2012 Jul 23.

4.

Squamous papilloma: an unusual esophageal entity.

Kanth P, Go MF.

Endoscopy. 2011;43 Suppl 2 UCTN:E405-6. doi: 10.1055/s-0030-1256936. Epub 2012 Jan 24. No abstract available.

PMID:
22275024
5.

Transcription and Translation.

Bhattacharyya S, Go MF, Dunn BE, Phadnis SH.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 26.

6.

Cytomegalovirus clostridium colitis disease in an immunocompetent patient.

Alkhatib AA, Tietze CC, Peterson KA, Go MF.

South Med J. 2009 Jul;102(7):775-6. doi: 10.1097/SMJ.0b013e3181a9030a. No abstract available.

PMID:
19488008
7.

Treatment and chemoprevention of NSAID-associated gastrointestinal complications.

Frech EJ, Go MF.

Ther Clin Risk Manag. 2009 Feb;5(1):65-73. Epub 2009 Mar 26.

8.

Treatment of Helicobacter pylori infection.

Vakil N, Go MF.

Curr Opin Gastroenterol. 2000 Jan;16(1):32-9.

PMID:
17024013
9.

Treatment of Helicobacter pylori.

Go MF, Vakil N.

Curr Opin Gastroenterol. 1999 Jan;15(1):72-8.

PMID:
17023921
10.

Drug injury in the upper gastrointestinal tract: nonsteroidal anti-inflammatory drugs.

Go MF.

Gastrointest Endosc Clin N Am. 2006 Jan;16(1):83-97.

PMID:
16546025
11.

NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.

Spiegel A, Hundley TR, Chen J, Gao J, Ouyang N, Liu X, Go MF, Tsioulias GJ, Kashfi K, Rigas B.

Biochem Pharmacol. 2005 Oct 1;70(7):993-1000.

PMID:
16105666
12.

Diagnosis and Treatment of Helicobacter pylori.

Go MF.

Curr Treat Options Gastroenterol. 2005 Apr;8(2):163-174.

PMID:
15769438
13.

Hepatitis C knowledge among primary care residents: is our teaching adequate for the times?

Coppola AG, Karakousis PC, Metz DC, Go MF, Mhokashi M, Howden CW, Raufman JP, Sharma VK.

Am J Gastroenterol. 2004 Sep;99(9):1720-5.

PMID:
15330909
14.

Synergy of Helicobacter pylori virulence factors and interleukin-1 polymorphisms in gastric cancer risk.

Go MF.

Curr Gastroenterol Rep. 2003 Dec;5(6):451-2. No abstract available.

PMID:
14602051
15.
16.

Endoscopic findings in uninvestigated dyspepsia.

Go MF.

Curr Gastroenterol Rep. 2003 Dec;5(6):449-50. No abstract available.

PMID:
14602049
17.

Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma.

Li L, Genta RM, Go MF, Gutierrez O, Kim JG, Graham DY.

Helicobacter. 2002 Dec;7(6):349-55.

PMID:
12485121
18.

Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions.

Li L, Graham DY, Gutierrez O, Kim JG, Genta RM, El-Zimaity HM, Go MF.

Dig Dis Sci. 2002 Nov;47(11):2512-8.

PMID:
12452388
19.

Treatment and management of Helicobacter pylori infection.

Go MF.

Curr Gastroenterol Rep. 2002 Dec;4(6):471-7. Review.

PMID:
12441037
20.

H. pylori and gastric cancer: the Asian enigma.

Miwa H, Go MF, Sato N.

Am J Gastroenterol. 2002 May;97(5):1106-12. Review.

PMID:
12014714
21.

Review article: natural history and epidemiology of Helicobacter pylori infection.

Go MF.

Aliment Pharmacol Ther. 2002 Mar;16 Suppl 1:3-15. Review.

22.

Helicobacter pylori infection in peptic ulcer disease and gastric malignancy.

Jones RG, Trowbridge DB, Go MF.

Front Biosci. 2001 Dec 1;6:E213-26. Review.

PMID:
11724680
23.

Peptic ulcer disease.

Smoot DT, Go MF, Cryer B.

Prim Care. 2001 Sep;28(3):487-503, v. Review.

PMID:
11483440
25.

An audit of the utility of in-patient fecal occult blood testing.

Sharma VK, Komanduri S, Nayyar S, Headly A, Modlinger P, Metz DC, Verghese VJ, Wanahita A, Go MF, Howden CW.

Am J Gastroenterol. 2001 Apr;96(4):1256-60.

PMID:
11316179
26.

Debating the role of Helicobacter pylori infection.

Vakil NB, Go MF.

Am J Manag Care. 2001 Feb;7(1 Suppl):S27-32. Review.

27.

Virulence and pathogenicity of Helicobacter pylori.

Go MF, Crowe SE.

Gastroenterol Clin North Am. 2000 Sep;29(3):649-70. Review.

PMID:
11030079
28.

Helicobacter pylori, gastric MALT lymphoma, and adenocarcinoma of the stomach.

Go MF, Smoot DT.

Semin Gastrointest Dis. 2000 Jul;11(3):134-41. Review.

PMID:
10950459
29.

A survey of internal medicine residents' knowledge about Helicobacter pylori infection.

Sharma VK, Bailey DM, Raufman JP, Elraie K, Metz DC, Go MF, Schoenfeld P, Smoot DT, Howden CW.

Am J Gastroenterol. 2000 Aug;95(8):1914-9.

PMID:
10950035
30.

Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypes.

Hansen PS, Go MF, Varming K, Andersen LP, Graham DY, Nielsen H.

APMIS. 1999 Dec;107(12):1117-23.

PMID:
10660142
31.

Genotypes of Helicobacter pylori obtained from gastric ulcer patients taking or not taking NSAIDs.

Li L, Kelly LK, Ayub K, Graham DY, Go MF.

Am J Gastroenterol. 1999 Jun;94(6):1502-7.

PMID:
10364014
32.

Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori in patients with different clinical presentations.

Hansen PS, Go MF, Varming K, Andersen LP, Genta RM, Graham DY, Nielsen H.

Infect Immun. 1999 Jun;67(6):3171-4.

33.

Practical advice on eradicating Helicobacter pylori infection.

Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE.

Postgrad Med. 1999 Mar;105(3):137-40, 145-8. Review.

PMID:
10086038
34.

Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis.

Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE.

Postgrad Med. 1999 Mar;105(3):113-6, 121-3, 127-8 passim. Review.

PMID:
10086037
35.

Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection?

Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE.

Postgrad Med. 1999 Mar;105(3):100-2, 105-8, 110. Review.

PMID:
10086036
36.

Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease.

Miehlke S, Genta RM, Graham DY, Go MF.

Am J Gastroenterol. 1999 Feb;94(2):364-8.

PMID:
10022630
37.
38.
39.

Frequency of vacA genotypes and cytotoxin activity in Helicobacter pylori associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Miehlke S, Meining A, Morgner A, Bayerdörffer E, Lehn N, Stolte M, Graham DY, Go MF.

J Clin Microbiol. 1998 Aug;36(8):2369-70.

40.

The effect of galE gene inactivation on lipopolysaccharide profile of Helicobacter pylori.

Kwon DH, Woo JS, Perng CL, Go MF, Graham DY, El-Zaatari FA.

Curr Microbiol. 1998 Aug;37(2):144-8.

PMID:
9662617
41.

REP-PCR fragments as biomarkers for differentiating gastroduodenal disease-specific Helicobacter pylori strains.

Kwon DH, El-Zaatari FA, Woo JS, Perng CL, Graham DY, Go MF.

Dig Dis Sci. 1998 May;43(5):980-7.

PMID:
9590411
42.

Failure to confirm association of vac A gene mosaicism with duodenal ulcer disease.

Go MF, Cissell L, Graham DY.

Scand J Gastroenterol. 1998 Feb;33(2):132-6.

PMID:
9517522
43.
45.

Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.

Miehlke S, Kibler K, Kim JG, Figura N, Small SM, Graham DY, Go MF.

Am J Gastroenterol. 1996 Jul;91(7):1322-5.

PMID:
8677987
47.

The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer.

Han SW, Evans DG, el-Zaatari FA, Go MF, Graham DY.

Am J Gastroenterol. 1996 Jun;91(6):1135-7.

PMID:
8651159
48.

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF.

Antimicrob Agents Chemother. 1996 Feb;40(2):477-80.

49.

"Modern therapies for Helicobacter pylori infection".

Go MF.

Acta Gastroenterol Latinoam. 1996;26(2):119-23. No abstract available.

PMID:
9137668
50.

NSAID-induced ulcers.

Go MF.

Acta Gastroenterol Latinoam. 1996;26(2):115-8. No abstract available.

PMID:
9137667

Supplemental Content

Support Center